Telix Pharmaceuticals
- Market cap
- 3.77B
- P/E (TTM)i
- 114.64
- P/Bi
- 9.07
- EPSi
- -0.02
- Div yieldi
- 0.00%
- 52W posi
- 71%
Anonymous reader poll. Unscientific, not investment advice.
Shares of Telix Pharmaceuticals closed at 11.12, up 3.15%. Its market capitalisation is about 3.77B, the #2345 most valuable US-listed company we track. The trailing P/E of 111.13 is 194% above its five-year average of 37.82. The 2 analysts covering the stock are, on balance, at Buy, targeting an average of 20.00 (+80%). Against a 52-week band of 6.28-13.11, the shares are currently 71% of the way up.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 month.
- Recent price momentum is +3.2% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Price chart
Performance
Key statistics
Price & volume
- Prev close
- 10.78
- Open
- 11.01
- Day range
- 11.00 - 11.14
- Avg price
- 11.10
- Volume
- 817.44K
- Turnover
- 9.07M
- Turnover ratei
- 0.30%
- Volume ratioi
- 3.11
- Amplitudei
- 1.30%
- 52-week rangei
- 6.28 - 13.11
Valuation
- P/Ei
- -529.52
- P/E (TTM)i
- 114.64
- P/Bi
- 9.07
- EPSi
- -0.02
- Book value / shi
- 1.23
- Net profit
- -7.11M
- Net assets
- 415.34M
Share structure
- Market cap
- 3.77B
- Float capi
- 3.02B
- Shares out
- 338.78M
- Float sharesi
- 271.65M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2024-11-14
15.2% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-456.88K net over the window
Short interest
- Shares short
- 352.52K
- % of floati
- 0.10%
- Days to coveri
- 1.00
- As of
- 2026-09-15
Frequently asked questions
What is the current stock price of Telix Pharmaceuticals (TLX)?
Telix Pharmaceuticals last traded at 11.12. The quote on this page refreshes every few seconds while US markets are open.
What is Telix Pharmaceuticals's market cap?
About 3.77B.
What is the P/E ratio of Telix Pharmaceuticals?
The trailing twelve-month P/E is 114.64, above its own 5-year average of 37.82 — in the middle of its historical range (41.03% percentile). See the Valuation tab for the full history.
Does Telix Pharmaceuticals pay a dividend?
Telix Pharmaceuticals does not currently pay a regular dividend.
Is Telix Pharmaceuticals a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 20.00, which implies 79.9% upside from the current price. This is not investment advice.
What is Telix Pharmaceuticals's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Telix Pharmaceuticals a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-10-08 07:11:57 · For reference only, not investment advice and not tailored to your situation.